U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 12-18, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 12-18, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 03/13/2023
Location: Virtual
Subject: Reagan-Udall Foundation Evidence Generation Roundtable
FDA Participant/Group: HANNAH JARMAN-MILLER; HILARY MARSTON;
Non FDA Participant/Group: Government, academia, and industry

Event Date: 03/13/2023
Location: Virtual
Subject: Human Foods Program
FDA Participant/Group: JULIA TIERNEY; JANET WOODCOCK; TRISTAN COLONIUS;
Non FDA Participant/Group: Jane Henney (University of Cincinnati Academic Health Center); Stephen Hahn (Flagship Pioneering); Mark McClellan (Duke University); David Kessler (University of California, San Francisco); Andrew Von Eschenbach (Samaritan Health); Scott Gottlieb (New Enterprise Associates); Margaret Hamburg (National Academy of Medicine);

Event Date: 03/14/2023
Location: Virtual
Subject: Infant Formula Supply and Production
FDA Participant/Group: SUSAN MAYNE; TRISTAN COLONIUS; JULIA TIERNEY; PETER BECKERMAN; RYAN NEWKIRK;
Non FDA Participant/Group: Christopher Calamari, Fiona Mullins, Hubert Allen, Margaret Creedon, Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 03/16/2023
Location: Virtual
Subject: America's Health Insurance Plans Health Policy and Markets Forum: Where Medicare, Medicaid, Duals and Commercial Come Together
FDA Participant/Group: ERICA JEFFERSON;
Non FDA Participant/Group: Government, industry, and media

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 03/15/2023
Location: Virtual
Subject: Equitable Breakthroughs in Medicine Development (EQBMED) Executive Committee Meeting
FDA Participant/Group: RICHARDAE ARAOJO;
Non FDA Participant/Group: Members of the EQBMED Executive Committee

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 03/15/2023
Location: Washington, DC
Subject: 27th Annual Research!America Advocacy Awards
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/14/2023
Location: Brussels, Belgium
Subject: Collaboration on Countering Illicit Trade
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Benedicte Fleischer (Organization for Economic Cooperation and Development);

Event Date: 03/14/2023
Location: Brussels, Belgium
Subject: Collaboration on Countering Illicit Trade
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Marion Jansen (Organization for Economic Cooperation and Development);

Event Date: 03/14/2023
Location: Paris, France
Subject: Exploration for Regulatory Cooperation
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Benoît Vallet (French Agency for Food, Environmental and Occupational Health & Safety );

Event Date: 03/15/2023
Location: Brussels, Belgium
Subject: Information Exchange on Relevant Mutual Global Activities
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Bob Diderich (Organization for Economic Cooperation and Development);

Event Date: 03/15/2023
Location: Brussels, Belguim
Subject: Health Related Priorities
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Francesca Colombo (Organization for Economic Development);

Event Date: 03/15/2023
Location: Paris, France
Subject: Information Sharing on Health Data Governance and Secondary Use
FDA Participant/Group: RITU NALUBOLA
Non FDA Participant/Group: Emmanuel Bacry (French Health Data Hub);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 03/12/2023
Location: Little Rock, AR
Subject: Arkansas Bioinformatics Consortium (AR-BIC) Annual Meeting; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and other government agencies

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/16/2023
Location: Virtual
Subject: Expansion of Special Government Employees (SGE) in Neuroscience
FDA Participant/Group: N/A
Non FDA Participant/Group: Merit Cudkowicz (Massachusetts General Hospital);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/15/2023
Location: Virtual
Subject: Advanced Therapies Congress 2023
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Advanced Therapies Congress 2023

Event Date: 03/15/2023
Location: Virtual
Subject: Center for Definitive and Curative Medicine 7th Annual Symposium; FDA's Regulatory Framework for Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Center for Definitive and Curative Medicine 7th Annual Symposium

Event Date: 03/17/2023
Location: Washington, DC
Subject: White House Summit; Assessing the Current State of Science and Bridging Gaps for Pan-SARS-CoV-2 and Pansarbecovirus Virus Candidates
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of White House Summit on Bridging Scientific Gaps on Correlates of Immune Protection for Next Generation Coronavirus Vaccines and Treatments

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/14/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Lesbian, Gay, Bisexual, Transgendered (LGBT) Cancer Network

Event Date: 03/14/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Robert Wasinger (McGuire Woods);

Event Date: 03/15/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Senator Edward Markey (D-MA)

Event Date: 03/16/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Association of State and Territorial Health Officials (ASTHO)

Event Date: 03/16/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Convenience Distribution Association (CDA)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 03/13/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ROSEMARY EARLEY; CINDY BURNSTEEL; AMBER MCCOIG; NADINE STEINBERG;
Non FDA Participant/Group: Representatives of the Alliance for Pharmacy Compounding

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top